Stocks and Investing Stocks and Investing
Thu, November 18, 2021
Wed, November 17, 2021
Tue, November 16, 2021
Mon, November 15, 2021

Corinne Jenkins Downgraded (BTAI) to Strong Sell and Decreased Target to $24 on, Nov 15th, 2021


Published on 2024-10-27 18:38:56 - WOPRAI
  Print publication without navigation


Corinne Jenkins of Goldman Sachs, Downgraded "BioXcel Therapeutics, Inc." (BTAI) to Strong Sell and Decreased Target from $55 to $24 on, Nov 15th, 2021.

Corinne, nor any peers, have made any analyst calls on BTAI in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30